Johnson & Johnson said on Tuesday Chief Scientific Officer Paul Stoffels, who spearheaded the development of the company’s single-shot COVID-19 vaccine, will retire at the end of this year.
The healthcare conglomerate did not immediately name Stoffels’ successor.
The announcement marks the second top management change at J&J in recent months. In August, the company said Joaquin Duato will succeed long-standing Chief Executive Officer Alex Gorsky.
Stoffels, who worked at J&J’s Janssen unit in the early 1990s, re-joined J&J in 2002 when the drugmaker acquired Virco and Tibotec, a Belgium-based drug developer, to expand its pipeline for HIV drugs. (Reporting by Manojna Maddipatla in Bengaluru; Editing by Shinjini Ganguli)